Clinical efficacy and safety of subcutaneous rituximab in non-Hodgkin lymphoma: a systematic literature review and meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical efficacy and safety of subcutaneous rituximab in non-Hodgkin lymphoma: a systematic literature review and meta-analysis

Published:2023-11-27 Issue:1 Volume:28 Page:
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Si Tianyu¹^ORCID,Ma Xiaolin¹,Zhu Wenwei¹,Zhou Yongming¹

Affiliation:

1. Department of Hematology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China

Funder

National Natural Science Foundation of China

National Administration of Traditional Chinese Medicine National Studio for Heritage of Famous Traditional Chinese Medicine Experts

the Seventh Batch of National Academic Experience Inheritance Work for Senior Experts in Traditional Chinese Medicine

Shanghai Clinical Key Specialty Construction Project

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/16078454.2023.2284047

Reference27 articles.

1. Epidemiology of Non-Hodgkin’s Lymphoma

2. CD20: a regulator of cell-cycle progression of B lymphocytes

3. Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience

4. Diffuse Large B-Cell Lymphoma

5. Follicular lymphoma

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Subcutaneous Rituximab in Idiopathic Nephrotic Syndrome;Kidney International Reports;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP